Clinical Trial: Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Breast Cancer
Study Type: OBSERVATIONAL
Official Title: A Multicenter Retrospective Analysis of the Miti-gene Recurrence Score in Early-Stage Invasive HR-Positive, HER2-Negative Breast Cancer in China
Brief Summary:
Update and validate the performance of the 21-gene score in prognostic stratification for early-stage HR-positive, HER2-negative breast cancer in China.
Read more